CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Advertisement

Nipro April 2026
High Quality, Fast Antibody Conjugates in Complete ELISA Kits
Drug Discovery, Development and Delivery

High Quality, Fast Antibody Conjugates in Complete ELISA Kits

Every immunoassay exploits the ability of an antibody (referred to as a primary antibody) to bind selectively to a particular target antigen, which is usually pr...
Continue Reading →
The Use of Preclinical Models to Drive Immunotherapy Cancer Research and Combination Strategies
Drug Discovery, Development and Delivery

The Use of Preclinical Models to Drive Immunotherapy Cancer Research and Combination Strategies

The ideal treatment for any disease is one that can cure it or prevent spreading with minimal impact on the patient’s quality of life. In the case of cancer, the...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026